Your Source for BioScience Venture Capital Data
  • OnBioVC NEWS:

    - OnBioVC Announces Beta Launch of Service
    - OnBioVC INDEX(TM) Updated thru JUN 2010
    - OnBioVC 2Q10 Trend Analysis, now available
    - OnBioVC 3Q10 Trend Analysis, coming soon
  • SEARCH THE OnBioVC DATABASE:

  • investment bank middle market venture capital

Complete Genomics (Mountain View, CA) a commercial-stage sequencing company building a human genome sequencing center to enable academic and biopharma researchers to conduct large-scale human genome studies, closed a $39M Series E financing. Participants include Sands Capital Management, Essex Woodlands, OVP Venture Partners, Prospect Venture Partners, OrbiMed Advisors, Highland Capital Management and Enterprise Partners.

Pacific Biosciences (Menlo Park, CA) developer of single molecule real-time nucleic acid and protein sequencing system closed a $50M Series F financing. Participants include Gen-Probe, Monsanto, the Wellcome Trust, Sutter Hill Ventures, Deerfield Management, Intel Capital, Morgan Stanley, Redmile Group, T. Rowe Price, Mohr Davidow Ventures, Kleiner Perkins Caufield and Byers, Alloy Ventures, Maverick Capital, [...]

Oxford Nanopore Technologies (United Kingdom) a development-stage medical device company focused on DNA sequencing via an electronic, label-free analysis of single molecule platform, closed a $28M Series C financing. Participants include Lansdowne Partners, IP Group, Invesco Perpetual and Illumina.

NABsys (Providence, RI) a development-stage company focused on polymerase-free solid-state electronic detection DNA sequencing free of amplification or labeling focused point-of-care clinical use, closed a $7M Series B financing. Participants include Stata Venture Partners and Point Judith Capital. _________________________________________________________________________
NOTE: New OnBioVC Friday feature coming, well…this Friday!

Pacific Biosciences (Menlo Park, CA) developer of single molecule real-time DNA sequencing system, closed a $68M Series E financing. Participants include Monsanto, Wellcome Trust, Sutter Hill Ventures, Deerfield Management, Intel Capital, Morgan Stanley, Redmile Group, T. Rowe Price, Mohr Davidow Ventures, Kleiner Perkins, Alloy Ventures, Maverick Capital, AllianceBernstein, DAG Ventures, Teachers’ Private Capital and Blackstone [...]

DNAnexus (Palo Alto, CA) a development-stage biocomputation company focused on a cloud computing platform infrastructure for the management DNA sequencing data, closed a $1.5M Series A financing. Participants include First Round Capital.

Complete Genomics (Mountain View, CA) a commercial-stage sequencing company building a human genome sequencing center to enable academic and biopharma researchers to conduct large-scale complete human genome studies, closed a $45M Series D financing. Participants include Essex Woodlands Health Ventures, OrbiMed Advisors, Enterprise Partners Venture Capital, OVP Venture Partners, Prospect Venture Partners and Highland Capital [...]

GenoLogics (Canada) a commercial-stage bioinformatics company focused on sequencing, genomic and proteomic data management, closed a $4M Series C financing. Participants include OVP Venture Partners, GrowthWorks and Yaletown Venture Partners.

Real Time Genomics (San Francisco, CA) an early-stage developer of developer of DNA sequencing analysis software, closed a $3M Series A financing. Participants include Catamount Ventures.

Blue Heron Biotechnology (Bothell, WA) a provider of gene synthesis services raised approximately $3.7M in Series D funding. Participants include Crabtree Ventures, Integra Ventures and Invitrogen.

« Previous Entries  

to top of page...